http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103784940-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 |
| filingDate | 2014-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103784940-B |
| titleOfInvention | Improve hematopoietic stem cell to go back to the nest and the method for implantation rate and reagent |
| abstract | The invention provides a kind of hematopoietic stem cell that improves to go back to the nest and the method for implantation rate and reagent.After described method comprises the steps: jointly to hatch containing the donorcells of hematopoietic stem cell and cationic peptide derivant, transplant cells in receptor body, go back to the nest to reach enhancing hematopoietic stem cell and implant, shortening the receptor hematopoietic reconstitution time, improve the effect of hematopoietic stem cell transplantation success rate.Present invention provides the application of cationic peptide derivant in preparation treatment disease in the blood system medicine. |
| priorityDate | 2014-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 139.